Enhancing Adjustment to Parental Cancer: Short-term Counselling for Families

Enhancing Adjustment to Parental Cancer: Short-term Counselling for Families. A Randomized, Wait-list Controlled Intervention Study

A parental cancer diagnosis challenges the family's stability and the parent-child relationship. It may impact the children's well-being, so that about one third of them develop clinically relevant levels of psychological distress. Psycho-oncological family-based counselling programs have been shown to elevate children's and parents' well-being. However, there is still a dearth of familial health services in Switzerland, which has also been recognized by the Swiss National Cancer Program (2011-2017).

This study aims to implement and evaluate a short-term family counselling intervention at the Cancer Center of the University Hospital Basel. The primary objective of the study is the enhancement of adjustment to the parental cancer diagnosis. The study seeks secondary to determine the feasibility of the short-term counselling Intervention.

Study Overview

Status

Completed

Detailed Description

This study ist designed as a randomized controlled wait-list Intervention study, which aims to implement and evaluate a short-term family counselling intervention at the Cancer Center of the University Hospital Basel. The study will be divided into two stages: Stage 1 serves as the preparatory work phase, where the intervention manual will be developed as well as the implementation strategy into the hospital. In stage 2 the intervention will be evaluated, with an interim analysis to test for feasibility. The primary objective of the study is the enhancement of adjustment (family, parents and children) to the parental cancer diagnosis. The study seeks secondary to determine the feasibility of the short-term counselling intervention in the Swiss medical setting and to identify predictors for families with continuing psychosocial adjustment problems.

Study Type

Interventional

Enrollment (Actual)

11

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Basel, Switzerland, 4031
        • University Hospital Basel

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Informed Consent as documented by signature
  • Diagnosis of any kind of cancer, inclusive relapse, within the last year with an expected survival of at least 8 months
  • Married, cohabiting or single parent
  • At least one child between 1-5 - 18 years
  • German speaking

Exclusion Criteria:

  • The diagnosis is more than 1 year ago
  • Diagnosed patients (parent) not living with their children
  • Diagnosed patients without custody of their children

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Counselling
short-term counselling for families
Counselling for Families which can take up to 6 weeks, with regular meetings under the guidance of a trained psychotherapist.
No Intervention: Wait-list control group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of children's quality of life on the health-related quality of life questionnaire (KINDL)
Time Frame: 6 weeks (change between baseline and week 6)
Enhancement of children's quality of life from T1 (baseline) to T2 (6 weeks) compared to the wait-list control group.
6 weeks (change between baseline and week 6)
Change of children's behavioral-emotional functioning on the Strengths and Difficulties Questionnaire (SDQ)
Time Frame: 6 weeks (change between baseline and week 6)
Enhancement of children's behavioral-emotional functioning from T1 (baseline) to T2 (6 weeks) compared to the wait-list control group.
6 weeks (change between baseline and week 6)
Change of parent's mental health on the Hospital Anxiety and Depression Scale (HADS)
Time Frame: 6 weeks (change between baseline and week 6)
Enhancement of parent's mental health from T1 (baseline) to T2 (6 weeks) compared to the wait-list control group.
6 weeks (change between baseline and week 6)
Change of family functioning on the Family Adaptability and Cohesion Evaluation Scale (FACES IV)
Time Frame: 6 weeks (change between baseline and week 6)
Enhancement of family functioning from T1 (baseline) to T2 (6 weeks) compared to the wait-list control group.
6 weeks (change between baseline and week 6)
Change of relationship quality on the relationship questionnaire (Partnerschaftsfragebogen PFB)
Time Frame: 6 weeks (change between baseline and week 6)
Enhancement of relationship quality from T1 (baseline) to T2 (6 weeks) compared to the wait-list control group.
6 weeks (change between baseline and week 6)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants willing to participate in the counselling
Time Frame: Through study completion, an average of 2 years
Secondary outcome will be to determine whether a short-term counselling intervention is feasible in the Swiss medical setting by collecting the number of participants willing to participate.
Through study completion, an average of 2 years
Sociodemographic characteristics (i.e. age, gender, education) of the participants willing to participate in the counselling with the sociodemographic questionnaire
Time Frame: Through study completion, an average of 2 years
Collecting sociodemographic characteristics of the population willing to participate with the sociodemographic questionnaire
Through study completion, an average of 2 years
Medical history characteristics (i.e. cancer diagnosis, cancer treatment) of the participants willing to participate in the counselling with the medical history questionnaire
Time Frame: Through study completion, an average of 2 years
Collecting medical history of the population willing to participate with the medical history questionnaire
Through study completion, an average of 2 years
Dropout rate during the recruitment and intervention procedure
Time Frame: Through study completion, an average of 2 years
Secondary outcome will be to determine whether a short-term counselling intervention is feasible in the Swiss medical setting by collecting dropout rate during the recruitment and intervention procedure.
Through study completion, an average of 2 years
Client satisfaction on the Client Satisfaction Questionnaire (CSQ-8)
Time Frame: Measures assessed after 6 weeks
German Version of the Client Satisfaction Questionnaire: Fragebogen zur Messung der Patientenzufriedenheit (ZUF-8) will be used to measure client's intervention satisfaction.
Measures assessed after 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 4, 2017

Primary Completion (Actual)

September 1, 2019

Study Completion (Actual)

September 1, 2019

Study Registration Dates

First Submitted

March 10, 2017

First Submitted That Met QC Criteria

March 24, 2017

First Posted (Actual)

March 31, 2017

Study Record Updates

Last Update Posted (Actual)

July 7, 2020

Last Update Submitted That Met QC Criteria

July 2, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Clinical Trials on Short-term Counselling for Families

Subscribe